Pharma sector to register 11% growth: study

May 2006
Chemical Business;May2006, Vol. 20 Issue 5, p69
Trade Publication
Forecasts the growth of the pharmaceutical industry by 2007 to 2008. Enlargement of the industry's exports to the regulated generic drug markets of the U.S. and Europe; Potential growth of the Indian pharmaceutical exports; Effect of the patent expirations of branded products to the growth of the industry.


Related Articles

  • CHAGING LANDSCAPES. Gray, Nicole // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p77 

    The article provides insights on the world's top 50 pharmaceutical companies. According to the IMS data, the global market registered a 7 percent growth in 2005, led by the biologics sector. It adds that the generic market registered a 13 percent growth. It notes that generic prescription volume...

  • UGANDA PHARMACEUTICALS & HEALTHCARE REPORT INCLUDES BMI'S FORECASTS.  // Uganda Pharmaceuticals & Healthcare Report;2013 1st Quarter, Issue 1, preceding p3 

    The article reports on the analysis of the trends in the pharmaceutical and healthcare industry in Uganda in the first quarter (Q1) of 2013 and offers industry forecasts for 2012-2021. It mentions threats to industry growth including low per-capita spending, poor access to healthcare facilities...

  • CONSUMER MARKETING: Update.  // Medical Marketing & Media;Jan2012, Vol. 47 Issue 1, p23 

    The article offers news briefs related to healthcare and pharmaceutical industry in the U.S., mentioning the advertising campaign launch by Presbyterian Hospital, the results of a survey on attitudes towards advertising and the survey that pushes the therapeutic substitution of generics drugs.

  • New in the marketplace. Adis International Limited // Drugs & Therapy Perspectives;Aug2004, Vol. 20 Issue 8, p26 

    The following table contains a summary of product launches and approvals identified in international markets in recent weeks by the drug therapy reporting service Inphama Weekly. Summarising information selected from over 1600 biomedical publications, this newsletter is produced by Adis...

  • India to Become a Key Pharma Manufacturing Hub. Scott, Alex // Chemical Week;8/30/2006, Vol. 168 Issue 29, p40 

    This article explains that the Indian pharmaceuticals sector is shifting from a focus on generics and becoming a regional hub for R& D, manufacturing, and export of ethical drugs, based on a recent report by consulting firm KPMG International. Opportunities for growth in ethical pharmaceutical...

  • Generics still riding high in 2007.  // European Pharmaceutical Executive;Feb/Mar2007, p17 

    The article reports on the increased interest in generics. The reduced contribution of new pharmaceutical products to overall market expansion has contributed to the growth of generics. The article reveals that generics are rapidly becoming the first-line option in a number of key therapy areas...

  • Research & Markets: The Essential 2011 Global Pharmaceuticals Industry Guide With Profiles of the Leading Companies in the Industry.  // Biomedical Market Newsletter;5/14/2011, p216 

    The article focuses on the "Global: Pharmaceuticals Industry Guide," which contains the profiles of the leading companies in the industry. The reports provides expert analysis with distinct chapters for generics, life sciences tools & services, pharmaceuticals, biotechnology and life sciences....

  • Pharmaceutical Business Environment Ratings.  // Canada Pharma & Healthcare Report;Q3 2009, p8 

    The article presents the business environment ratings for the pharmaceutical industry of Canada for the third quarter of 2009. Accordingly, the country ranks third among the ten Americas markets surveyed, with the U.S. and Puerto Rico being in the first and second places, respectively. The...

  • Pharma Antes Up in 2010, Will 2011 Look Even Better? Orelli, Brian // BioWorld Insight;1/3/2011, Vol. 19 Issue 1, p1 

    The article reports developments in the pharmaceutical industry worldwide for 2010. According to data released by MedTRACK, a biomedical database from Life Science Analytics, pharmaceutical deals were up 20 percent year to date through October 2010 compare to the same period in 2009. It also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics